ABVX
Abivax S.A.
95.10$
-4.0%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | – | |
| 14.6% | 16.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 100.0% | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | – | |
| 1,451.2% | 3,033.3% | – | 852.0% | – | 531.2% | – | 1,916.0% | – | – | – | – | – | |
| 292.9% | 672.1% | – | 344.7% | – | 117.9% | – | 441.7% | – | – | – | – | – | |
| 1,744.0% | 3,958.9% | – | 1,041.1% | – | 637.9% | – | 2,305.2% | – | – | – | – | – | |
| -1,758.7% | -3,975.2% | – | -1,041.1% | – | -637.9% | – | -2,305.2% | – | – | – | – | – | |
| 653.9% | 245.1% | – | 112.8% | – | 61.3% | – | 174.6% | – | – | – | – | – | |
| -2,410.5% | -4,215.2% | – | -1,142.6% | – | -707.8% | – | -2,400.3% | – | – | – | – | – | |
| -99.4% | -97.1% | – | – | – | – | – | – | – | – | – | – | – | |
| -2,311.1% | -4,118.1% | – | -1,142.7% | – | -707.8% | – | -2,400.3% | – | – | – | – | – | |
| -1,744.0% | -3,958.9% | – | -1,019.1% | – | -642.8% | – | -2,213.3% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.